Aimei Health Receives Nasdaq Delisting Notices for MVLS and MVPHS Deficiencies
AFJK sits 82% above its 52-week low of $6.75 on light trading volume (0.2× avg).
Summary
Aimei Health received two Nasdaq deficiency notices for falling below minimum market value thresholds, with a February 17, 2027 compliance deadline. The company faces delisting risk amid an already distressed SPAC situation.
Key Events · Legal and Risk Events · AFJK
-
Nasdaq MVLS Deficiency Notice
On August 21, 2026, Nasdaq notified Aimei Health that its Market Value of Listed Securities was below $50 million for 30 consecutive business days, violating Listing Rule 5450(b)(2)(A).
-
Nasdaq MVPHS Deficiency Notice
A separate notice on the same date flagged Market Value of Publicly Held Shares below $15 million for 30 consecutive business days, violating Listing Rule 5450(b)(2)(C).
-
Compliance Deadline
The company has 180 calendar days, until February 17, 2027, to regain compliance with both requirements; compliance requires 10 consecutive business days above the thresholds.
-
Delisting Risk
If compliance is not regained, Nasdaq will issue a delisting notice. The company may apply to transfer to the Nasdaq Capital Market, but there is no assurance of success.
Analysis · AFJK · Real Estate & Construction
Aimei Health Technology received two Nasdaq deficiency notices on August 21, 2026: its Market Value of Listed Securities fell below $50 million and its Market Value of Publicly Held Shares fell below $15 million, each for 30 consecutive business days. The company has until February 17, 2027 to regain compliance. This lands on top of an already precarious situation — the SPAC's business combination with United Hydrogen was terminated in July, Q2 2026 showed a net loss with near-zero operating cash and a going-concern warning, and the business combination deadline is now just weeks away. A delisting would severely impair liquidity and the company's ability to complete any future combination.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 43.9% of the 999 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.15%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AFJK was trading at $12.28 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $38.9M. The 52-week trading range was $6.75 to $130.37. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.